Frequently Asked Questions

How do I submit a grant request to the AGO?

The process for grant submission is described on the "Grant Process" page. Click here to review the process.

In which therapeutic classes does the AGO accept grant requests?

The AGO currently reviews grant proposals in the diabetes therapeutic area. AGO occasionally reviews educational grants in other related metabolic areas like Obesity and Lipodystrophy. In diabetes, prioritization will be given to healthcare professional educational activities focused on the role of amylinomimetics and GLP-1 receptor agonists, and the prevention of long term complications of diabetes. Only limited funding is available for other metabolic education.

Does previous support of a program indicate likely support of future grants?

No, each grant request is evaluated on its individual merit relative to other similar grant requests and available budget.

Can my Amylin contact help me get my grant request approved?

If the grant is for CME/CE or other independent medical education, your Amylin contact cannot help you get your grant approved. If the request is for a philanthropic purpose, your Amylin contact may provide help subject to committee review.

Is there a way to track the progress of my grant Request?

You may track the progress of your grant through your registration site for all the grant requests you have outstanding. You will receive a direct communication from the AGO immediately following a decision.

How will I know if my grant is approved?

You may track the progress of your grant through your registration site for all the grant requests you have outstanding. You will receive a direct communication from the AGO immediately following a decision.

Please do not consider any request approved until you have received written documentation from the AGO approving your grant request.

If approved, will Amylin publicly disclose the details of my grant request?

Beginning in January, 2009, Amylin will publicly post its accumulative grant funding on a quarterly basis. The first quarterly report is to be posted prior to May 30, 2009 and will include the following information:

Name of the Organization
Purpose of the funding
Amount

Subsequent reports will follow within 60 days of the close of the quarter.

Therefore, as a condition of receiving grant funds from Amylin, any potential grantee organization must agree to public disclosure.

Who sits on the evaluation committee?

The evaluation committee is made up of cross functional personnel capable of reviewing requests for merit, legal compliance, and subject matter expertise.

Can Amylin help with speaker, content, or design recommendations for my CME/CE program?

No, the AGO adheres to the guidelines and regulations promulgated by the ACCME and other applicable regulatory agencies.

If I need more money to complete the activity, can I request more funding?

You may request additional funds for a program through an amended application submitted from your registration site. It will be reviewed under the same process as a new grant request.

If I spend less than estimated, how do I return funds?

You should contact the AGO at AmylinGrantOffice@Amylin.com for further instructions.

What criteria are used to determine funding?

The criteria used for funding are described in each grant type that Amylin funds. You can review these criteria by clicking on the grant type on the AGO homepage. Click here to go to the AGO homepage.

What items are generally outside the scope of the AGO?

Activities and items typically outside the scope are described in each grant type that Amylin funds. You can review these criteria by clicking on the grant type on the AGO homepage. Click here to go to the AGO homepage.

What documentation is required for a grant request to be reviewed?

• Completed on-line application
• A single Adobe Acrobat document (.pdf) including the following: